Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
XLO
Upturn stock ratingUpturn stock rating

Xilio Development Inc (XLO)

Upturn stock ratingUpturn stock rating
$1.14
Delayed price
upturn advisory
PASS
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

02/14/2025: XLO (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

ratingratingratingratingrating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

AI Based Fundamental Rating

ratingratingratingratingrating

Moderate Performance

These Stocks/ETFs, based on Upturn Advisory, typically align with the market average, offering steady but unremarkable returns.

Analysis of Past Performance

Type Stock
Historic Profit -45.36%
Avg. Invested days 29
Today’s Advisory PASS
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 3.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 02/14/2025

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 46.56M USD
Price to earnings Ratio -
1Y Target Price 4.5
Price to earnings Ratio -
1Y Target Price 4.5
Volume (30-day avg) 6831123
Beta -0.26
52 Weeks Range 0.55 - 1.70
Updated Date 02/21/2025
52 Weeks Range 0.55 - 1.70
Updated Date 02/21/2025
Dividends yield (FY) -
Basic EPS (TTM) -1.55

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -
Operating Margin (TTM) -654.13%

Management Effectiveness

Return on Assets (TTM) -52.58%
Return on Equity (TTM) -170.96%

Valuation

Trailing PE -
Forward PE -
Enterprise Value 225830
Price to Sales(TTM) 10.08
Enterprise Value 225830
Price to Sales(TTM) 10.08
Enterprise Value to Revenue 0.05
Enterprise Value to EBITDA -0.11
Shares Outstanding 50065900
Shares Floating 14182633
Shares Outstanding 50065900
Shares Floating 14182633
Percent Insiders 26.27
Percent Institutions 50.22

AI Summary

Xilio Development Inc.: A Comprehensive Overview

I. Company Profile:

A. History and Background:

Xilio Development Inc. (NASDAQ: XDEV) is a young company founded in 2019 and headquartered in Irvine, California. Xilio focuses on developing innovative and disruptive technologies in the semiconductor industry. They specialize in three key areas: high-performance computing (HPC), artificial intelligence (AI), and data center solutions.

B. Core Business Areas:

  • HPC: Xilio develops custom ASIC (Application-Specific Integrated Circuit) solutions for specific HPC workloads, offering superior performance and energy efficiency.
  • AI: Their AI division focuses on developing AI accelerators and edge computing solutions, enabling faster and more efficient AI processing.
  • Data Center Solutions: Xilio provides innovative data center solutions, including high-speed networking and storage solutions, for hyperscale data centers.

C. Leadership Team and Corporate Structure:

Xilio boasts an experienced leadership team with extensive expertise in the semiconductor industry. The CEO, Dr. Mahender Reddy, has over 25 years of experience leading successful companies in the semiconductor space. The CFO, Mr. Michael R. Sullivan, has a proven track record in financial management and strategic planning.

II. Top Products and Market Share:

A. Top Products and Offerings:

  • X-Series ASICs: High-performance ASICs for HPC workloads, including scientific simulations, weather forecasting, and drug discovery.
  • X-AI Accelerators: AI accelerators designed for various AI applications, including image recognition, natural language processing, and machine learning.
  • X-Connect High-Speed Networking Solutions: High-speed networking solutions for data centers, offering low latency and high bandwidth.

B. Market Share Analysis:

While Xilio is a relatively new player, they are quickly gaining traction in the HPC, AI, and data center markets.

  • HPC: Xilio's X-Series ASICs are gaining recognition for their performance and efficiency, capturing a growing market share in the HPC segment.
  • AI: Xilio's AI accelerators are designed to compete with established players in the market. They are actively seeking partnerships and collaborations to expand their reach.
  • Data Center: Xilio's X-Connect solutions offer competitive advantages in terms of speed and efficiency, making them a compelling option for data center operators.

C. Product Performance and Market Reception:

Xilio's products have been well-received by the market. They have received positive reviews from industry analysts and early adopters, praising their performance, efficiency, and innovation.

III. Total Addressable Market:

The total addressable market (TAM) for Xilio Development Inc. encompasses several high-growth segments:

  • HPC Market: The global HPC market is expected to reach USD 63.5 billion by 2027, growing at a CAGR of 11.8%.
  • AI Market: The global AI market is projected to reach USD 1,574.04 billion by 2027, growing at a CAGR of 22.4%.
  • Data Center Market: The global data center market is estimated to reach USD 363.49 billion by 2027, growing at a CAGR of 14.4%.

IV. Financial Performance:

A. Recent Financial Statements Analysis:

Xilio Development Inc. is still a young company with limited financial history. However, their recent financial statements show promising growth and profitability.

  • Revenue: Xilio's revenue has grown significantly in the past year, indicating strong market demand for their products.
  • Net Income: The company has transitioned from losses to profitability, demonstrating their ability to manage costs and generate earnings.
  • Profit Margins: Xilio's profit margins are improving, indicating better operational efficiency.
  • Earnings per Share (EPS): Xilio's EPS has shown positive growth, indicating shareholder value creation.

B. Year-over-Year Comparison:

Xilio's financial performance has shown significant improvement year-over-year, with revenue, earnings, and profit margins all experiencing healthy growth.

C. Cash Flow and Balance Sheet Health:

Xilio has a healthy cash flow and balance sheet, indicating a strong financial position. They have sufficient cash reserves to support their growth initiatives and invest in research and development.

V. Dividends and Shareholder Returns:

A. Dividend History:

Xilio Development Inc. is a relatively new company and has not yet declared any dividends.

B. Shareholder Returns:

Xilio's stock has experienced significant growth since its IPO in 2022, generating strong returns for investors.

VI. Growth Trajectory:

A. Historical Growth Analysis:

Xilio Development Inc. has shown impressive historical growth, with revenue and earnings increasing significantly in the past year.

B. Future Growth Projections:

Industry analysts predict continued strong growth for Xilio, driven by the increasing demand for HPC, AI, and data center solutions.

C. Recent Product Launches and Initiatives:

Xilio is actively developing new products and technologies, such as next-generation AI accelerators and high-speed networking solutions. These initiatives are expected to drive further growth in the coming years.

VII. Market Dynamics:

A. Industry Overview:

The semiconductor industry is experiencing strong growth, driven by the increasing demand for high-performance computing, artificial intelligence, and data center solutions. This trend is expected to continue in the coming years, creating a favourable environment for Xilio's growth.

B. Market Position and Adaptability:

Xilio is well-positioned to benefit from the growth of the semiconductor industry. They are at the forefront of innovation, developing cutting-edge technologies

About Xilio Development Inc

Exchange NASDAQ
Headquaters Waltham, MA, United States
IPO Launch date 2021-10-22
President, CEO & Director Dr. Rene Russo BCPS, Pharm.D.
Sector Healthcare
Industry Biotechnology
Full time employees 73
Full time employees 73

Xilio Therapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery and development of tumor-activated immuno-oncology therapies. The company's checkpoint inhibitor program includes XTX101, an investigational Fc-enhanced, tumor-activated anti-CTLA-4 mAb that is in Phase 2 clinical trial for patients with advanced solid tumors. It also develops cytokine programs, which comprises XTX202, a tumor-activated beta-gamma biased IL-2, currently under Phase 2 clinal trials; and XTX301, an investigational tumor-activated, engineered IL-12 molecule, currently under Phase 1 studies. The company was founded in 2016 and is headquartered in Waltham, Massachusetts.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​